Pluri (NASDAQ:PLUR) Issues Earnings Results

Pluri (NASDAQ:PLUR) issued its earnings results on Tuesday. The company reported ($0.53) earnings per share (EPS) for the quarter, Zacks reports. Pluri had a negative net margin of 4,184.28% and a negative return on equity of 917.18%.

Pluri Trading Up 1.8 %

Shares of PLUR traded up $0.08 during mid-day trading on Thursday, reaching $4.45. The stock had a trading volume of 1,086 shares, compared to its average volume of 12,347. Pluri has a 52-week low of $4.07 and a 52-week high of $8.48. The firm has a market cap of $24.74 million, a price-to-earnings ratio of -0.74 and a beta of 1.67. The business’s fifty day moving average is $4.50 and its 200 day moving average is $4.98. The company has a debt-to-equity ratio of 4.44, a current ratio of 5.90 and a quick ratio of 5.90.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.